FGAM
ARKG icon

Financial Gravity Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Financial Gravity Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-252
Closed -$7K – 1381
2019
Q3 		$7K Sell
252
-543
-68% -$17.6K 0.01% 649
2019
Q2 		$27K Buy
+795
New +$25.5K 0.02% 433

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
CAN
Claraphi Advisory Network Aliso Viejo, United States $251M AUM 9.29% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Financial Gravity Asset Management's ARKG Position: Q4 2019 in Review

Financial Gravity Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2019, closing a stake of 252 shares — an estimated $7K sold.

Financial Gravity Asset Management first reported a position in ARKG in Q2 2019 and held it in 2 quarters. The position peaked at $27K in Q2 2019. 93 funds tracked by Wall St. Rank hold ARKG as of Q4 2019.

  • Financial Gravity Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2019 after selling out during the quarter.
  • Financial Gravity Asset Management sold 252 ARK Genomic Revolution ETF shares in Q4 2019, an estimated $7K.
  • Financial Gravity Asset Management first reported a position in ARK Genomic Revolution ETF in Q2 2019 and held it in 2 quarters.
  • Financial Gravity Asset Management's ARK Genomic Revolution ETF position peaked at $27K in Q2 2019.
  • 93 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2019.

Based on Financial Gravity Asset Management's 13F filing for Q4 2019, filed 28 Feb 2020.